Jean-LucSzpakowskiMD

PubMed

• 2 citations
  Iron deficiency and symptoms in women aged 20-49 years and relation to upper gastrointestinal and colon cancers.
  Jean-Luc Szpakowski, Lue-Yen Tucker> ;BMJ Open Gastroenterology. 2022 Jul 1
• 1 citations
  Survey Study on the Experience, Practice Patterns, and Preferences of the Fellows of the Society of Radiologists in Ultrasound for Evaluation and Management of Gallbla...
  William D Middleton, Christopher Fung, Nirvikar Dahiya, Jean-Luc Szpakowski, Michael T Corwin, David T Fetzer, Helena Gabriel, Mitchell E Tublin, Andrew J Walsh, Aya K...> ;Ultrasound Quarterly. 2022 Jun 1
• Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study.
  Jean-Luc Szpakowski, Lue-Yen Tucker, David M Baer, Mary Pat Pauly> ;Canadian Liver Journal. 2022 Jan 1
• 30 citations
  Outcomes of Gallbladder Polyps and Their Association With Gallbladder Cancer in a 20-Year Cohort
  Jean-Luc Szpakowski, Lue-Yen Tucker> ;JAMA Network Open. 2020 May 1
• 40 citations
  Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists
  Mary Patricia Pauly, Lue Yen Tucker, Jean Luc Szpakowski, Joanna Ready, David Baer, Jessica P. Hwang, Anna S.F. Lok> ;Clinical Gastroenterology and Hepatology. 2018 Dec 1
• 19 citations
  Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study.
  Jean-Luc Szpakowski, Todd E. Drasin, Liisa Lyon> ;Hepatology Communications. 2017 Sep 29
• 34 citations
  Causes of death in patients with hepatitis B: A natural history cohort study in the United States
  Jean-Luc Szpakowski, Lue-Yen Tucker> ;Hepatology. 2013 Jul 1
• Join now to see all

Journal Articles

• Outcomes of Gallbladder Polyps and Their Association With Gallbladder Cancer in a 20-Year Cohort  
  Jean-Luc Szpakowski, MD and Lue-Yen Tucker, BA, JAMA Network Open, 5/18/2020
• Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study  
  Jean-Luc Szpakowski, Todd E. Drasin, Liisa L. Lyon, Hepatology Communications
• Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists  
  Mary Patricia Pauly, Lue-Yen Tucker, Jean-Luc Szpakowski, Joanna B. Ready, David Baer, Jessica Hwang, Anna S. Lok, Clin Gastoenterol Hepatol, 1/1/2018
• Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study Hepatology Communications, 1: 841–851. doi:10.1002/hep4.1089  
  Jean-Luc Szpakowski, Todd E. Drasin, Liisa L. Lyon, Hepatology Communications, 9/29/2017
• Prescribing Proton Pump Inhibitors for Initial Treatment of Acid-related Gastrointestinal Diseases in a Managed Care Population  
  Chan J, Hui R, Szpakowski, J-L, Am J Manag Care, 1/1/2004
• Economic impact of PPI vs H2 receptor antagonists in the management of acid related disorders-�return on investment  
  Chan James, Hui Rita, Szpakowski Jean-Luc, Gastroenterology, 1/1/2002
• Liver transplantation�experience with 100 case  
  Szpakowski, Jean-Luc, Cox, Ken, Nakazato, Paul, Concepcion, Waldo, Levin, Barry, Esquivel, Carlos, West J Med, 1/1/1991
• Liver transplantation—experience with 100 cases  
  Szpakowski, Jean-Luc; Cox, Ken; Nakazato, Paul; Concepcion, Waldo; Levin, Barry; Esquivel, Carlos, West J Med, 1/1/1991
• Join now to see all

Books/Book Chapters

• Drugs and the Liver: High Risk Patients and Transplantation 
  Chapter: Practical uses of OKT3 
  Page 143 - 148Esquivel C, Nakazato P, Concepcion W, Szpakowski J-L, Gettys C, Lim JEditors: Galamarin D.1993

Abstracts/Posters

• Hepatotoxicity with Chemotherapy in Patients Infected with Hepatitis C
  Jean-Luc Szpakowski, Lue-Yen Tucker, David Baer, Marypat Pauly, EASl; Journal of Hepatology, 1/1/2016
• Simeprevir/Sofosbuvir Therapy in Hepatitis C (HCV) Infected Patients With Child-Pugh Class B/C Cirrhosis Compared to Matched Untreated and Protease Inhibitor (PI)-Trip...
  Varun Saxena, Lisa M. Nyberg, Mary Patricia Pauly, Joanna Ready, Jean-Luc Szpakowski, Barbara Piasecki, Anders H. Nyberg, Bradley J. Winston, Jacquelyn L. Redd, Lisa C..., AGA; Gastroenterology, 1/1/2015
• Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C (HCV) infected Patients with varying severity of Cirrhosis: comparison to matched untreated and Protease In...
  V. Saxena, L. Nyberg, M. Pauly, J. Ready, J.-L. Szpakowski, B. Piasecki, A. Nyberg, B. Winston, J. Redd, L. Catalli, A. Dasgupta, S. Straley, K. Sommer, G. Witt, R. Ra..., EASl; Journal of Hepatology, 1/1/2015
• Predicting Recurrent Hepatocellular Carcinoma and Survival after Liver Transplantation: The importance of time to transplant
  Mary Patricia Pauly, Bradley Winston, Jean-Luc Szpakowski, Lisa M. Nyberg, David H. Smith, Jin Sun, Alice Ducey, Celia D. Clarke, Barbara Piasecki, Ruth Brentari, AASLD; Hepatology, 1/1/2014
• Hepatotoxicity with Chemotherapy in patients Infected with Hepatitis B virus
  Szpakowski, L. Tucker, D. Baer, M. Pauly, D. Hwang, J. Nanfro, AASLD Emerging Trends Conference: Reactivation of Hepatitis B, 1/21/2013
• Comparative effectiveness and safety of boceprevir and telaprevir for chronic genotype 1 hepatitis C in a community setting
  Aimee R. Loucks, JimChan, Rita L. Hui, Michele M. Spence,, Jean-Luc Szpakowski, AASLD; Hepatology, 1/1/2013
• Risk of seeding with biopsies of hepatocellular carcinoma: A United States Community Perspective
  Jean-Luc Szpakowski, Liisa L. Lyon, Todd E. Drasin, AASLD; Hepatology, 1/1/2013
• Hepatotoxicity with Chemotherapy in patients Infected with Hepatitis B virus
  Szpakowski, L. Tucker, M. Pauly, D. Hwang, J. Nanfro, D. Baer, Meetings of the Americian Society of Clinical Oncology; J Clin Oncol, 1/1/2013
• Causes of Death in HBV: a US Natural History Cohort Study for Almost 10 Years
  Jean-Luc Szpakowski, Lue-Yen Tucker, Annual meeting of the AASLD; Hepatology, 1/1/2009
• The Influence of Cigarette Smoking on Response to Treatment with Prgylated Interferon alpha-2b and ribavirin in Patients with Chronic Hepatitis C
  Mary P Pauly, Alan J Scheinbaum, Jeann-Luc Szpakowski, Joanna B. ready, Robert S. Brown, Bradley Freilich, Nezam Afdahl, Paul Kwo, John Ssantoro, Scott Becker, Ira Jac..., Gastroenterology, 1/1/2008
• Hepatitis C (HCV) patients have a higher cost of care and this is not fully explained by the high number of comorbid conditions
  MP Pauly, JB Ready, JL Szpakowski, Z Lin, T Cuff, T Sowerby, Gastroenterology; DDW, 1/1/2001
• The cost of care in Hepatitis C is due to comorbid medical condition until the development of decompensated cirrhosis
  MP Pauly, JB Ready, JL Szpakowski, T Cuff, T Sowerby, KT Esrason, N Terrault, Hepatology; AASLD, 1/1/1999
• Sigmoidoscopy is sufficient for evaluation of �outlet� hematochezia: a three year outcome study
  Szpakowski, J-L, DDW; Gastroenterology, 1/1/1998
• Join now to see all

Lectures

• Reactivation of Hepatitis B (HBV) in Patients Treated with Anti-Tumor Necrosis Factor (anti-TNF) Agents 
  1/9/2014
• Hepatitis B and C Update 
  1/11/2007
• Principles of Gastroenterology for the Nurse Practitioner and Physician Assistant 
  1/7/2007
• Treatment of Hepatitis C 
  1/5/2000
• Treatment, Research and the Future for Liver Disease 
  Kaiser Permanente Oakland Medical Center, Oakland, CA - 1/16/1999
• Join now to see all

Other

• H pylori treatment Revisited 
  Szpakowski, J-L, Drug Bulletin Kaiser Permanente
  1/1/1997
• H pylori treatment: How, Who, What 
  Szpakowski, J-L, Drug Bulletin Kaiser Permanente
  1/1/1995